Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Persistent psychotic symptoms will develop in up to 60% of patients with Parkinson disease (PD). The initial approach to the management of PD psychosis (PDP) begins with addressing concurrent systemic conditions associated with psychotic behavior, such as delirium, medical conditions (eg, infections...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007727/
データ提供：米国国立医学図書館（NLM）
Treating Psychotic Symptoms in Parkinson's Disease
This research delves into the critical realm of managing psychotic symptoms in Parkinson's disease (PD). It's like navigating a vast desert, where every step is crucial to ensure a stable journey. This study employed a systematic approach, analyzing the most effective methods for addressing these challenging symptoms.
A Multifaceted Approach to Managing PD Psychosis
The findings highlight the importance of a comprehensive strategy, starting with addressing any underlying medical or psychiatric conditions that might contribute to the psychosis. It's like clearing the sand dunes and ensuring a clear path before embarking on the real journey. This involves a thorough review of medications and, if possible, reducing or eliminating those that might trigger psychotic symptoms. The goal is to strike a delicate balance – improving drug-related psychotic symptoms while not significantly worsening the motor symptoms of PD, much like carefully navigating a tricky desert terrain.
Second-Generation Antipsychotics: A Potential Oasis
When additional measures are needed for chronic PDP treatment, the study recommends exploring second-generation antipsychotics, such as clozapine, pimavanserin, or quetiapine. These drugs offer a potential oasis in the desert of PD psychosis, providing relief without the significant side effects of their first-generation counterparts. In patients with comorbid dementia, the addition of a cholinesterase inhibitor might also be beneficial.
Dr.Camel's Conclusion
This research provides valuable insights into the complex management of PD psychosis. It emphasizes a multi-pronged approach, focusing on identifying and addressing underlying factors, carefully adjusting medications, and exploring the potential benefits of second-generation antipsychotics. Remember, managing PD psychosis is a journey through a challenging landscape, and this study equips us with the necessary tools to navigate it effectively.
Date :
- Date Completed n.d.
- Date Revised 2020-09-29
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.